A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

Weight-loss injections are dominating the market: Where will GLP-1 pills fit in? Glucagon-like peptide-1 (GLP-1) medications have emerged as powerful tools for weight loss. So far, injectable options ...

As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Subscribe to our ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder treatment, recently introduced injectable medications as a new treatment ...

GLP-1 medications mimic a natural hormone that controls appetite, blood sugar, and digestion. Monthly costs range from $199 to over $1,300, depending on the specific medication and insurance coverage.

Since they debuted, injectable GLP-1 drugs like Ozempic have been in high demand. In addition to treating diabetes and obesity, these medications have cardiovascular benefits, and there’s evidence ...

Nigeria has received its first consignment of long-acting injectable Lenacapavir, a new HIV prevention option expected to ...